MedPath

TTP-435

Generic Name
TTP-435

Safety Study of the Inhibition of Agouti-related Protein (AgRP) for the Management of Obesity and Weight Loss

Phase 2
Completed
Conditions
Obesity
Interventions
Drug: Placebo
First Posted Date
2008-10-24
Last Posted Date
2011-06-27
Lead Sponsor
vTv Therapeutics
Target Recruit Count
100
Registration Number
NCT00779519
© Copyright 2025. All Rights Reserved by MedPath